Home > Boards > US Listed > Biotechs > Marker Therapeutics Inc (MRKR)

$TPIV: Q&A w Director of CMC operations at TapImmune

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
BiotechValues Member Profile
 
Followed By 340
Posts 10,238
Boards Moderated 2
Alias Born 06/23/07
160x600 placeholder
Marker Therapeutics Announces that Data from Investigator-Sponsored Phase 1 Study With its MultiTAA-Specific T Cells to be Presented at the 2021 American Society of Hematology Annual Meeting PR Newswire (US) - 11/18/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/15/2021 7:11:46 AM
Marker Therapeutics EPS misses by $0.02 Seeking Alpha - 11/10/2021 4:38:10 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2021 4:11:12 PM
Marker Therapeutics Reports Third Quarter 2021 Operating and Financial Results PR Newswire (US) - 11/10/2021 4:05:00 PM
Marker Therapeutics to Present at Three Upcoming September Investor Conferences PR Newswire (US) - 9/7/2021 4:05:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/20/2021 6:03:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/19/2021 4:13:47 PM
Marker Therapeutics Awarded $13.1 Million Grant from the Cancer Prevention and Research Institute of Texas PR Newswire (US) - 8/19/2021 4:05:00 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/10/2021 5:11:55 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/10/2021 4:03:08 PM
Marker Therapeutics Reports Second Quarter 2021 Operating and Financial Results PR Newswire (US) - 8/10/2021 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/28/2021 4:36:58 PM
Marker Therapeutics opens new cGMP manufacturing facility in Houston Seeking Alpha - 7/28/2021 4:13:52 PM
Marker Therapeutics Announces Opening of New cGMP Manufacturing Facility PR Newswire (US) - 7/28/2021 4:05:00 PM
Marker Therapeutics completes safety lead-in portion of mid-stage leukemia study Seeking Alpha - 7/6/2021 7:50:03 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2021 7:24:18 AM
Marker Therapeutics Announces Completion of Safety Lead-In Portion of Phase 2 Study in Post-Transplant AML PR Newswire (US) - 7/6/2021 7:00:00 AM
Marker Therapeutics to Present at the Virtual Raymond James Human Health Innovation Conference PR Newswire (US) - 6/16/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2021 8:01:22 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2021 6:58:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2021 6:57:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2021 6:55:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2021 6:55:01 PM
Marker Therapeutics EPS misses by $0.02 Seeking Alpha - 5/12/2021 4:22:10 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences